Skip to main content

How ELAHERE may help you be here

Patient portrayal.

Progression-free survival Progression-free survival Overall survival Response rates

ELAHERE may help stop cancer from progressing

In a clinical study of 453 people with FRα+ platinum-resistant ovarian cancer, ELAHERE helped extend the time to disease progression compared with traditional chemotherapy.

Graphic of a coral magnifying glassDefine:FRα+: A biomarker test result that means you have a certain amount of FRα on the surface of your cancer cells. If your ovarian cancer is FRα positive, ask your doctor if ELAHERE is right for you.Platinum-resistant ovarian cancer: When your ovarian cancer comes back or progresses after receiving a type of chemotherapy that contains platinum.Median progression-free survival: The length of time that the treatment stops the cancer from growing or getting worse for half of the people. A median is the middle number in a group of numbers that are listed from lowest to highest.Traditional chemotherapy: Traditional chemotherapy in the clinical study included anticancer drugs that are not targeted and do not contain a material called platinum.

FRα=folate receptor alpha.

Median progression-free survival

ELAHERE logo

(227 people)

Graphic of a calendar showing 5.6 months
vs

Traditional
chemotherapy

(226 people)

Graphic of a calendar showing 4.0 months

More time without the cancer growing or spreading with ELAHERE

Some people taking ELAHERE lived longer

In the same clinical study, ELAHERE was proven to help people live longer compared with traditional chemotherapy.

Graphic of a coral magnifying glassDefine:Median overall survival: The length of time that half of the people were alive after starting treatment. A median is the middle number in a group of numbers that are listed from lowest to highest.

Median overall survival

ELAHERE logo

(227 people)

Graphic of a calendar showing 16.5 months
vs

Traditional
chemotherapy

(226 people)

Graphic of a calendar showing 12.7 months

A chance for better response is here

The study also found that more people’s tumors shrank by at least 30% or disappeared when treated with ELAHERE vs when treated with traditional chemotherapy. The decrease in tumor size lasted a median of 6.8 months in those treated with ELAHERE and 4.5 months in those treated with traditional chemotherapy.

Overall response*

42% of people achieved an overall response with ELAHERE, and 16% of people achieved an overall response with traditional chemotherapy. 42% of people achieved an overall response with ELAHERE, and 16% of people achieved an overall response with traditional chemotherapy.

*In the clinical study, 225 people treated with ELAHERE and 224 people treated with traditional chemotherapy were eligible to be evaluated for overall response.

Graphic of a white magnifying glassDefine:Overall response: A measure of all people who had either a complete or partial response.Complete response: A measure of the people who had no signs of cancer on a follow-up scan.Partial response: A measure of the people whose tumors shrank by at least 30%.

Graphic of a caution symbol

Curious about side effects?

Learn about the possible side effects of treatment with ELAHERE.

Review the Safety
Graphic of a stethoscope

Talk with your doctor about ELAHERE

For help starting a conversation with your doctor, personalize this discussion guide.

Build Your Discussion Guide
Graphic of an envelope

Stay up-to-date with ELAHERE

Receive helpful resources and treatment tips right in your email inbox.

Sign Up